Pharmacare bill offers too much ambiguity and too little ambition

To understand and maximize value, we should know why the government chose this odd-duck model, and diabetes and contraception drugs over others. Politics over public health, perhaps?
Mark Holland
Health Minister Mark Holland has suggested the national pharmacare plan would initially cost about $1.5-billion annually, but that depends on the scope and pace of those bilateral agreements, writes Chris Bonnett.

For decades, pharmacare has been a day late and a dollar short. How much did Bill C-64 change that?

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE Opinion

RELATED STORIES